Teva, Mylan Win Toss Of Allergan Ulcer Drug Patent Suit

Law360, San Jose (October 25, 2017, 5:19 PM EDT) -- A Texas federal judge on Tuesday dismissed a suit brought by Allergan USA subsidiary Warner Chilcott against Teva Pharmaceuticals USA Inc. and Mylan Pharmaceuticals Inc. alleging infringement of its ulcerative colitis drug Delzicol, and put off ruling on counterclaims from the defendants to allow their generic alternatives to go forward.

The ruling from U.S. District Judge Rodney Gilstrap affirmed a decision by U.S. Magistrate Judge Roy Payne, who recommended that motions for summary judgment filed by Mylan and Teva be granted and a judgment of noninfringement...
To view the full article, register now.